UK think-tank calls for genetic testing strategy
This article was originally published in Clinica
Executive Summary
The UK National Health Service (NHS) has been criticised for failing to set out a coherent strategy for the provision of genetic testing and counselling. A report from the Institute for Public Policy Research (IPPR), a centre-left think-tank, has warned that the NHS will not be able to meet future demand for genetic services.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.